Streetbeat News

Stock Prices

AKBA

In the past 3 months, 8 analysts have published their opinions on Akebia Therapeutics (NASDAQ:AKBA) stock, with an average 12-month price target of $2.16, up 33.33% from the previous average of $1.62. The majority of analysts are indifferent, with 7 out of 8 giving neutral ratings.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 9:00 pm

PEPG

Analysts have provided bullish and somewhat bullish ratings for PepGen (NASDAQ:PEPG) in the last quarter, with an average price target of $24.0, up 41.18% from the previous average of $17.00. The current price of PepGen is $12.2.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 9:00 pm

ELOX

Eloxx Pharmaceuticals announced that ELX-02 demonstrated clinically relevant improvement in ppFEV1 in the final data assessment. This supports the company's decision to advance into a pivotal trial in Alport syndrome.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 8:57 pm

LEN

Lennar Corp (NYSE:LEN) reported better-than-expected Q2 results, with revenues of $8.04 billion and EPS of $2.94. The company delivered 17,074 homes and received 17,885 new orders in Q2. Lennar expects Q3 home deliveries to be between 17,750 and 18,250, with a gross margin of 23.5% to 24%.

Portfolio Pulse from Adam Eckert

June 14, 2023 | 8:48 pm

MRK

QQQ

SPY

TSLA

Benzinga's ChatGPT portfolio, crafted by OpenAI's ChatGPT, has outperformed seven of the top 10 US equity funds after five weeks, with a 7.21% gain. The AI-built portfolio now ranks fourth, with Tesla Inc (NASDAQ:TSLA) being the best performing stock, up 53%, and Merck & Co Inc (NYSE:MRK) being the worst performer, down 6.64%.

Portfolio Pulse from AJ Fabino

June 14, 2023 | 8:45 pm

ACB

Aurora Cannabis (NASDAQ:ACB) reported Q3 earnings with an EPS of $-0.18, missing estimates by 260.0%. Revenue was up $7.54 million YoY. Last quarter, the company missed EPS by $0.09, resulting in a 1.09% share price drop the next day.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:45 pm

LEN

Lennar Corporation has increased its FY23 home deliveries forecast from 62,000-66,000 to 68,000-70,000 homes.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 8:43 pm

LEN

Lennar Corporation reported better-than-expected Q2 earnings results, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 8:43 pm

LEN

Lennar Corporation expects to deliver 17,750-18,250 homes with a gross margin of 23.5%-24.0% in Q3.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 8:41 pm

LEN

Lennar Corporation (NYSE:LEN) reported Q2 earnings with an EPS of $2.94, beating estimates by 26.72%. However, revenue was down $314 million compared to the same period last year.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 8:40 pm